Cointime

Avelas Biosciences

company

About

Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.

  • 11 - 50

Highlights

Total Funding Amount
$20M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$20M
Industries
Biotechnology,Life Science,Real Time
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
Avelas Biosciences has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Aug 18, 2016 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 18, 2016 Series C $20M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Avelas Biosciences is funded by 1 investors. Inbio Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Inbio Ventures — Series C
Cointime
เนื้อหา
บริษัท